Control Bionics was featured in an article on JETRO’s site announcing the expansion of our AAC technology into Japan. The article discusses Control Bionics’ NeuroNode Trilogy system, which combines touch control and eye control in addition to EMG, to reduce fatigue due to less susceptibility to posture and light conditions, as well as ease of work for caregivers with wireless technology.
In August 2021, Control Bionics established a Japanese branch in Tokyo, and in April 2022, signed an exclusive distribution agreement with Double Research and Development Co., Ltd. Control Bionics plans to launch our product in May, and will start full-scale operations to better solve the communication challenges of people with severe disabilities in Japan through technology.
